Regulatory Affairs
IND, CTA, BLA, DSUR, FDA briefing packages, and documentation alignment.
View regulatory supportPharma · Biologics · Global Development
Systems-level regulatory clarity for drug and biologic development.
Integrated perspective
Mari gathers information across clinical, manufacturing, quality, and CMC teams to diagnose regulatory issues and ensure compliant, complete submissions for global health authorities.
Core capabilities
IND, CTA, BLA, DSUR, FDA briefing packages, and documentation alignment.
View regulatory supportCMC issue resolution, dossier consistency, biosimilar support, and global submissions.
View CMC supportQMS remediation, non-conformance investigation, vendor and CMO audits, and cGMP oversight.
View quality supportMove forward with clarity